Evaluation of UCP1162, a potent propargyl-linked inhibitor of dihydrofolate reductase with potential application to cancer and autoimmune diseaseBIOCHEMICAL PHARMACOLOGYIF5.62024-12-010PRE
Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogensCOMMUNICATIONS BIOLOGYIF5.12022-05-1314OAAI
Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant Staphylococcus aureusACS INFECTIOUS DISEASESIF3.82019-09-3025OAAI